Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system

Immunologic Research

Volumn 16, Issue 3, 1997, Pages 243-259

  Smith, Kelly D ^a   Kurago, Zoya B ^a   Lutz, Charles T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antibody; Conformation; Cytolytic T lymphocyte; Epitope; HLA B7; Mhc class I; NK cell; Peptide; T cell receptor

Indexed keywords

EPITOPE; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; CONFORMATIONAL TRANSITION; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030708645     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786393     Document Type: Review

References (109)

1. Spriggs MK: One step ahead of the game-viral immunomodulatory molecules.Annu Rev Immunol 1996;14:101-130.
2. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995;375:685-688.
3. Hill A, Jugovie P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D: Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995;375:411-415.
4. Früh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 1995;375:415-418.
5. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996;84:769-779.
6. Bevan MJ: The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med 1975;142:1349-1364.
7. Germain RN: MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 1994;76:287-299.
8. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michei H, Sevilir N, Cox AL, Appella E, Engelhard VH: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992;255:1261-1263.
9. Huczko EL, Bodnar WM, Benjamin D, Sakaguchi K, Zhu NZ, Shabanowitz J, Henderson RA, Appella E, Hunt DF, Engelhard VH: Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 1993;151:2572-2587.
10. b/ Science 1992;257:919-927.
11. Madden DR, Garboczi DN, Wiley DC: The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA A2. Cell 1993;75:693-708.
12. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-221.
13. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA 1995;92:2479-2483.
14. Madden DR: The three-dimensional structure of peptide-MHC complexes. Ann Rev Immunol 1995; 13:587-622.
15. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996;384: 134-141.
16. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA: An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR MHC complex. Science 1996;274:209-219.
17. Smith KJ, Reid SW, Harlos K, McMichael AJ, Stuart DI, Bell JI, Jones KY: Bound water structure and polymorphic amino ac:ids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 1996;4: 215-228.
18. Smith KJ, Reid SW, Stuart DI, McMichael AJ, Jones KY, Bell JI: An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 1996;4:203-213.
19. b at 2.4 Å resolution: implications for antigen-determinant selection. Cell 1994;76: 39-50.
20. Guo H-C, Madden DR, Silver ML, Jardetzky TS, Gorga JC, Strominger JL, Wiley DC: Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*680I, HLA-A*0201, and HLA-B*2705. Proc Natl Acad Sci USA 1993;90:8053-8057.
21. Davies DR, Padian EA, Sheriff S: Antibody-antigen complexes. Annu Rev Biochem 1990;59:439-473.
22. Benjamin DC, Berzofsky JA, East IJ, Gurd FRN, Hannum C, Leach SJ, Margoliash E, Michael JG, Miller A, Prager EM, et al.: The antigenic structure of proteins: A reappraisal. Ann Rev Immunol 1984;2:67-101.
23. Jin L, Fetidly BM, Wells JA: High resolution functional analysis of antibody-antigen interactions. J Mol Biol 1992;226:851-865.
24. Jin L, Wells JA: Dissecting the energetics of an antibody-antigen interface by alanine shaving and molecular grafting. Proc Sci 1994;3:2351-2357.
25. Collawn JF, Wallace CJA, Proudfoot AEI, Paterson Y: Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome c. J Biol Chem 1988;263:8625-8634.
26. Cunningham BC, Jhurani P, Ng P, Wells JA: Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 1989;243: 1330-1336.
27. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R: Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompalibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 1988;85:227-231.
28. Smith KD, Mace BE, Valenzuela A, Vigna JL, McCutcheon JA, Barbosa JA, Huczko E, Engelhard VH, Lutz CT: Probing HLA-B37 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J Immunol 1996; 157:2470-2478.
29. 2-microglobulin heterodimers in an allele-specific manner, and association is influenced by peptide binding groove residues. J Immunol 1996; 157:4503-4510.
30. Ways JP, Parham P: The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies. J Immunol 1983;131:856-863.
31. Tanabe M, Sekimata M, Ferrone S, Takiguchi M: Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 1992,148:3202-3209.
32. 2-microglobulin. Eur J Immunol 1987; 17:1257-1263.
33. Brodsky FM, Parham P: Evolution of HLA antigenic determinants: Species cross reactions of monoclonal antibodies. Immunogenetics 1982; 15:151-166.
34. Saper MA, Bjorkman PJ, Wiley DC: Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 1991;219:277-319.
35. Van Rood JJ, van Leeuwen A: Leukocyte grouping. A method and its application. J Clin Invest 1963;42:1382-1390.
36. Arnaiz-Villena A, Belvedere M, Decary F, Fotino M, Heise E, Hogan V, Martinetti M, Muller C, Richiardi P, Vicario JL, et al.: Antigen society #15 report (Bw4 and Bw6); in Dupont B (ed): Immunobiology of HLA, vol 1. New York, Springer-Verlag, 1989, pp 214-217.
37. Wan AM, Ennis P, Parham P, Holmes N: The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/ Bw6 epitopes. J Immunol 1986; 137:3671-3674.
38. Lutz CT, Smith KD, Greazel NS, Mace BE, Jensen DA, McCutcheon JA, Goeken NE: Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the αc-1 helix. J Immunol 1994; 153:4099-4110.
39. Barbosa JA, Santos-Aguado J, Mentzer SJ, Strominger JL, Burakoff SJ, Biro PA: Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. J Exp Med 1987;166:1329-1350.
40. McCutcheon JA, Lutz CT: Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum Immunol 1992;35:125-131.
41. McCutcheon JA, Smith KD, Valenzuela A, Aalbers K, Lutz CT: HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum Immunol 1993;36:69-75.
42. Bluestone JA, Jameson S, Miller S, Dick R, II: Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J Exp Med 1992; 176:1757-1761.
43. Catipovic B, Dal Porto J, Mage M, Johansen TE, Schneck JP: Major histocompatibility complex conformational epitopes are peptide specific. J Exp Med 1992;176: 1611-1618.
44. Hogquist KA, Grandea lil AG, Bevan MJ: Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur J Immunol 1993;23:3028-3036.
45. d serologic recognition. J Immunol 1993; 151 :5387-5397.
46. Wang J, Yu DTY, Fukazawa T, Kellner H, Wen J, Cheng X-K, Roth G, Williams KM, Raybourne RB: A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol 1994;152:1197-1205.
47. Ajitkumar P, Geier SS, Kesari KV, Borriello F, Nakagawa M, Bluestone JA, Saper MA, Wiley DC, Nathenson SG: Evidence that multiple residues on both the α-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 1988;54:47-56.
48. b using a monoclonal antibody. Biochem Biophys Res Commun 1992;186:1449-1454.
49. Nathenson SG, Geliebter J, Pfaffenbaeh GM, Zeff RA: Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications. Ann Rev Immunol 1986; 4:471-502.
50. Bluestone JA, Kallyaperumal A, Jarneson S, Miller S, Dick R, II: Peptide-induced conformational changes in class I heavy chains alters allorecognition. J Immunol 1993; 151 :3943-3953.
51. Sherman LA, Chattopadhyay S, Biggs JA, Dick RF, II, Bluestone JA: Alloantibodiescan discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Acad Sci USA 1993;90:6949-6951.
52. 51a Smith KD, Epperson DF, Lutz CT: Alloreactive cytotoxic T-lymphocyte-defined HLA B7 subtypes differ in peptide antigen presentation. Immunogenetics 1995;43:27-37.
53. Parham P, Antonelli P, Herzenberg LA, Kipps TJ, Fuller A, Ward FE: Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum Immunol 1986; 15:44-67.
54. Smith KD, Lutz CT: Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions, of the MHC class I long α-helices. J Immunol 1997;158:2805-2812.
55. Madden DR, Gorga JC, Strominger JL, Wiley DC: The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992;70: 1035-1048.
56. 54a Reid SW, McAdam S, Smith KJ, Klenerman P, O'Callaghan CA, Harlos K, Jakobsen BK, McMichael AJ, Bell JI, Stuart DI, et al.: Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 1996;184:2279-2286.
57. Rotzschke O, Falk K, Faath S, Ranamensee H-G: On the nature of peptides involved in T cell alloreactivity. J Exp Med 1991; 174:1059-1071.
58. Heath WR, Kane KP, Mescher MF, Sherman LA: Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc Natl Acad Sci USA 1991;88:510-5105.
59. Villadangos JA, Galocha B, López, de Castro JA: Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J Immunol 1994;152:2317-2323.
60. Li Y-Y, Smith KD, Shi Y, Lutz CT: Allloreactive anti-HLA-B7 cytolytic T cell clones use restricted T cell receptor genes. Transplantation 1996;62:954-961.
61. Smith KD, Huczko E, Englehard VH, Li Y-Y, Lutz CT: Alloreactive cytotoxic T lymphocytes focus on specific major histocampatibility complex-bound peptides. Transplantation 1997;64:351-359.
62. Peccoud J, Dellabona P, Allen P, Elenoist C, Mathis D: Delineation of antigen contact residues on an MHC class II molecule. EMBO J 1990;9:4215-4223.
63. Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC: A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 1988;332:845-850.
64. Lombardi G, Matsui M, Moots R, Aichinger G, Sidhu S, Batchelor R, Frelinger J, Lechler R: Limited regions of the α2-domain α-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants. Immunogenetics 1991; 34:149-156.
65. Moots RJ, Matsui M, Pazmany L, McMichael AJ, Frelinger JA: A cluster of mutations of HLA-A2 α2 helix abolishes peptide recognition by T cells. Immunogenetics 1991; 34:141-148.
66. d molecules. J Immunol 1992;149: 3390-3994.
67. b imolecule. Immunity 1995;3:573-582.
68. Braden BC, Souchon H, Eisele J-L, Bently GA, Bhat TN, Navaza J, Poijak RJ: Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1. J Mol Biol 1994;243:767-781.
69. Cunningham BC, Wells JA: High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 1989;244:1081-1085.
70. de Vos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992;255:306-312.
71. Somers W, Ultsch M, de Vos AM, Kossiakoff M: The x-ray structure of a growth hormone-prolactin receptor complex. Nature 1994;372:478-481.
72. Clackson T, Wells JA: A hot spot of binding energy in a hormone-receptor interface. Science 1995; 267:383-386.
73. Enrich EW, Devaux B, Rock EP, Jorgensen JL, Davis MM, Chien Y-h: T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J Exp Med 1993;178:713-722.
74. Chien Y-h, Davis MM: How αβ T-cell receptors "see" peptide-MHC complexes. Immunol Today 1993; 14:597-602.
75. Tulip WR, Varghese JN, Webster RG, Laver WG, Coiman PM: Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. J Mol Biol 1992;227: 149-159.
76. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989;47: 187-376.
77. Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE: NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol 1991;147:3244-3250.
78. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619-648.
79. Yokoyama WM: Recognition structures on natural killer cells. Curr Opin Immunol 1993;5:67-73.
80. Rojo S, Burshtyn DN, Long EO, Wagtmann N: Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol 1997;158:9-12.
81. Wang LL, Mehta IK, LeBlanc PA, Yokoyama WM: Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J Immunol 1997;158:13-17.
82. Perez-Villar JJ, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, Lopez-Botet M: Functional ambivalence of the Kp43 (CD94) NK cell associated surface antigen. J Immunol 1995;154:5779-5788.
83. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, López-Botet M, et al.: Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994;180:545-555.
84. Brumbaugh KM, Perez-Villar JJ, Dick CJ, Schoon RA, López-Botet M, Leibson PJ: Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol 1996; 157:2804-2812.
85. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH: Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996; 157:4741-4745.
86. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL: CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and H LA-C allotypes. Immunity 1996; 5:163-172.
87. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A: CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 1996;26:2487-2492.
88. Phillips JH, Gumperz JE, Parham P, Lanier LL: Superantigen-dependent, cell mediated cytotoxicity inhibited by MHC class I receptors on lymphocytes. Science 1995;268:403-405.
89. D'Andrea A, Chang C, Phillips JH, Lanier LL: Regulation of T-cell lymphokine production by killer cell inhibitory receptcor recognition of self HLA class I alleles. J Exp Med 1996;184:789-794.
90. Mandelboim O, Davis DM, Reyburn HT, Vales-Gomez M, Sheu KG, Pazmany L, Strominger JL: Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 1996;274:2097-2100.
91. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO: Recruitment of tyrosiine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77-85.
92. Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, et al.: Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 1996;156:4531-4534.
93. Fry AM, Lanier LL, Weiss A: Phoslphotyrosines in the killer cell inhibitory receptormotif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 1996;184:295-300.
94. + T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 1991; 147:714-721.
95. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L: Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995;182:875-884.
96. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural kilier cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183:645-650.
97. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-408.
98. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-449.
99. Colonna M, Brooks KG, Falco M, Ferrara GB, Strominger JL: Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993;260:1121-1124.
100. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donate C, Parham P, Moretta L: Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995;182:605-609.
101. Mandelboim O, Reyburn HT, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G, Strominger JL: Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996;184: 913-922.
102. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: NKB1: An NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994;180:537-543.
103. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P: The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:1133-1144.
104. Kurago ZB, Smith KD, Lutz CT: NK cell recognition of MHC class I-NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells. J Immunol 1995;154:2631-2641.
105. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995;267:1016-1018.
106. Peruzzi M, Parker KC, Long EO, Malnati MS: Peptide sequence requirements for the recognition of HLA-B*2705 by specifiic natural killer cells. J Immunol 1996;157:3350-3356.
107. Peruzzi M, Wagtmann N, Long EO: A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 1996;184:1585-1590.
108. b complex. Eur J Immunol 1997;27:227-233.
109. Gumperz JE, Barber LD, Valiante NM, Percival L, Phillips JH, Lanier LL, Parham P: Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition of the NKB1 killer cell-inhibitory receptor. J Immunol 1997;158:5237-5241.